Search

Your search keyword '"Wilmer Flores"' showing total 2 results
Start Over Author "Wilmer Flores" Publisher ovid technologies (wolters kluwer health)
2 results on '"Wilmer Flores"'

1. PF205 RNA BASED IMMUNE SIGNATURES MAY PREDICT RESPONSES TO PD-1 INHIBITION AND AZACITIDINE TREATMENT IN ACUTE MYELOID LEUKEMIA (AML): A SUBSET ANALYSIS OF A PHASE 2 STUDY

Author

F. Wang, J. E. Cortes, Courtney D. DiNardo, H. Kantarjian, T. Kadia, E. Jabbour, R. Davis, Mansour Alfayez, Naval Daver, Marina Konopleva, M. Andreeff, S. Kornblau, G. Garcia-manero, S. Neelapu, F. Ravandi, Gautam Borthakur, J. Mathews, Wilmer Flores, and Hussein A. Abbas

Subjects
Subset Analysis, Immune system, business.industry, Azacitidine, Cancer research, RNA, Medicine, Myeloid leukemia, Phases of clinical research, Hematology, business, medicine.drug
Published
2019

2. S1615 SAFETY, EFFICACY, AND BIOMARKERS OF RESPONSE TO AZACITIDINE (AZA) WITH NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI), AND AZA WITH NIVO IN R/R ACUTE MYELOID LEUKEMIA: A NON-RANDOMIZED, PHASE 2 STUDY

Author

P. Sherry, Rita Assi, G. Nogueras Gonzalez, Naval Daver, Padmanee Sharma, Michael Andreeff, Hussein A. Abbas, Marina Konopleva, Naveen Pemmaraju, Kenichiro Takahashi, Courtney Dinardo, Jairo Matthews, E. Jabbour, Steven M. Kornblau, James P. Allison, Wilmer Flores, Tapan M. Kadia, Zeev Estrov, Hagop M. Kantarjian, Jorge E. Cortes, Jing Ning, Mansour Alfayez, Guillermo Garcia-Manero, Sreyashi Basu, and Farhad Ravandi

Subjects
Oncology, medicine.medical_specialty, business.industry, Internal medicine, Azacitidine, Medicine, Phases of clinical research, Myeloid leukemia, Ipilimumab, Hematology, Nivolumab, business, medicine.drug
Published
2019

Catalog

Books, media, physical & digital resources
See catalog results